4-Hydroxy-2-quinolones. 168. Synthesis, chemical and antitubercular properties of 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides

1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather tha...

Full description

Saved in:
Bibliographic Details
Published inChemistry of heterocyclic compounds (New York, N.Y. 1965) Vol. 45; no. 9; pp. 1058 - 1068
Main Authors Ukrainets, I. V, Grinevich, L. A, Tkach, A. A, Bevz, O. V, Slobodzian, S. V
Format Journal Article
LanguageEnglish
Published Boston Boston : Springer US 01.09.2009
Springer US
Springer Nature
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather than in the amide part of the molecule. The 1-N-allyl derivative behaves similarly but undergoes halocyclization to give 2-bromomethyl-5-oxo-1,2-dihydro-5H-oxazolo[3,2-a]quinoline-4-carboxylic acid pyrazin-2-ylamide. A comparative analysis of the antimycobacterial properties of the synthesized compounds and their isomeric pyrimidin-2-ylamides has been carried out.
AbstractList 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather than in the amide part of the molecule. The 1-N-allyl derivative behaves similarly but undergoes halocyclization to give 2-bromomethyl-5-oxo-1,2-dihydro-5H-oxazolo[3,2-a] quinoline-4-carboxylic acid pyrazin-2-ylamide. A comparative analysis of the antimycobacterial properties of the synthesized compounds and their isomeric pyrimidin-2-ylamides has been carried out.
1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather than in the amide part of the molecule. The 1-N-allyl derivative behaves similarly but undergoes halocyclization to give 2-bromomethyl-5-oxo-1,2-dihydro-5H-oxazolo[3,2- a ]quinoline-4-carboxylic acid pyrazin-2-ylamide. A comparative analysis of the antimycobacterial properties of the synthesized compounds and their isomeric pyrimidin-2-ylamides has been carried out.
Author Slobodzian, S. V
Ukrainets, I. V
Grinevich, L. A
Tkach, A. A
Bevz, O. V
Author_xml – sequence: 1
  fullname: Ukrainets, I. V
– sequence: 2
  fullname: Grinevich, L. A
– sequence: 3
  fullname: Tkach, A. A
– sequence: 4
  fullname: Bevz, O. V
– sequence: 5
  fullname: Slobodzian, S. V
BookMark eNqNkEFvFCEYhompidvqD_Akd8vKBzPMzNFs1Jo0MbH2TBj4pkszCyvMxI5_xr9atmN6NB4IAd7nBZ5zchZiQELeAt8C582HDLzuJOO8Y1y2FVMvyAbqRrJW1vKMbPjpRIIQr8h5zvdl2UBbbcifil0tLsWHhQn2c_YhjqU4bymodktvljDtMft8Se0eD96akZrgypj8NPeY7DyaRI8pHjFNHjONAwX2nVVs_9waHyKDS8Gcf9pbL_EBmWTWpL6ERm-psd7R45LMbx8KtIzm4B3m1-TlYMaMb_7OF-T286cfuyt2_e3L193Ha2bLpyaGDTdVB071qlUcQIERg-UVCtf3iKZWXaOM6bltOmiF6KVEizW4zg4OnJMXBNZem2LOCQd9TP5g0qKB65NhvRrWxaM-GdaqMO3K_MI-Dtl6DBafuaJYNFXd8UJzrnZ-MpOPYRfnMBX0_f-jJS3WdC6JcIdJ38c5heLjn697t0KDidrcJZ_17Y3gIDk0AFBL-QgEqavm
CitedBy_id crossref_primary_10_1002_chin_201018166
crossref_primary_10_1016_j_bioorg_2019_103291
Cites_doi 10.1016/j.bmcl.2007.11.049
10.1128/AAC.46.4.977-981.2002
10.1021/jm020310n
10.1128/AAC.01494-06
10.1007/s10593-009-0367-7
10.1128/AAC.01369-06
10.1128/AAC.01458-06
10.1002/ardp.200700119
10.1007/s10593-009-0297-4
10.1107/S1600536808013378
10.1128/AAC.00356-07
10.3390/11040242
10.2174/157340607780620635
10.1002/9783527616091
ContentType Journal Article
Copyright Springer Science+Business Media, Inc. 2009
Copyright_xml – notice: Springer Science+Business Media, Inc. 2009
DBID FBQ
1KM
BLEPL
DTL
GDOUO
AAYXX
CITATION
DOI 10.1007/s10593-009-0384-6
DatabaseName AGRIS
Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 2009
CrossRef
DatabaseTitle Web of Science
CrossRef
DatabaseTitleList Web of Science


Database_xml – sequence: 1
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
– sequence: 2
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1573-8353
EndPage 1068
ExternalDocumentID 10_1007_s10593_009_0384_6
000274590100006
US201301711153
GrantInformation_xml – fundername: National Institute for Allergic and Infectious Diseases, USA; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
  grantid: 01-AI-45246
GroupedDBID -4Y
-58
-5G
-BR
-EM
-Y2
-~C
-~X
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
28-
29B
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAGCJ
AAHNG
AAIAL
AAIKT
AAJKR
AANZL
AARHV
AARTL
AATNV
AATVU
AAUCO
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPTK
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACSNA
ACTTH
ACVWB
ACWMK
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFEXP
AFGCZ
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJGSW
AJRNO
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
B0M
BA0
BBWZM
BDATZ
BGNMA
CAG
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EAD
EAP
EBLON
EBS
EIOEI
EJD
EMK
EPL
ESBYG
ESX
FBQ
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HF~
HG6
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IAO
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
LAK
LLZTM
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P9N
PF0
PT4
PT5
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
RNS
ROL
RPX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3B
SAP
SCG
SCLPG
SCM
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SQXTU
SRMVM
SSLCW
STPWE
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
TUS
TWZ
U2A
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
W4F
WIP
WJK
WK8
XU3
YLTOR
Z7R
Z7U
Z7V
Z7W
Z7X
Z7Y
Z7Z
Z86
Z87
Z8M
Z8O
Z8P
Z8Q
Z8S
Z8T
Z91
ZE2
ZMTXR
~8M
~A9
~EX
~KM
AAPBV
1KM
AACDK
AAJBT
AASML
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
AAEOY
AAYXX
AGJZZ
CITATION
ID FETCH-LOGICAL-c312t-e70a491d6b68601161a2fc04e2dbbeea56976aab0c791822b33ece51d9cfd1dd3
IEDL.DBID U2A
ISICitedReferencesCount 6
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000274590100006
ISSN 0009-3122
IngestDate Thu Sep 12 18:22:39 EDT 2024
Wed Sep 18 00:11:23 EDT 2024
Fri Nov 01 20:04:34 EDT 2024
Sat Dec 16 12:03:28 EST 2023
Wed Dec 27 19:23:11 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords X-ray structural analysis
antitubercular activity
1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides
2-aminopyrazine
bromination
VITRO
ANTIMYCOBACTERIAL
T-705
IN-VIVO ACTIVITIES
DERIVATIVES
PYRAZINE
Language English
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c312t-e70a491d6b68601161a2fc04e2dbbeea56976aab0c791822b33ece51d9cfd1dd3
Notes http://dx.doi.org/10.1007/s10593-009-0384-6
ORCID 0000-0002-7302-4922
0000-0003-3762-8670
PageCount 11
ParticipantIDs webofscience_primary_000274590100006
fao_agris_US201301711153
crossref_primary_10_1007_s10593_009_0384_6
springer_journals_10_1007_s10593_009_0384_6
webofscience_primary_000274590100006CitationCount
PublicationCentury 2000
PublicationDate 2009-09-01
PublicationDateYYYYMMDD 2009-09-01
PublicationDate_xml – month: 09
  year: 2009
  text: 2009-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: NEW YORK
PublicationTitle Chemistry of heterocyclic compounds (New York, N.Y. 1965)
PublicationTitleAbbrev Chem Heterocycl Comp
CHEM HETEROCYCL COM
PublicationYear 2009
Publisher Boston : Springer US
Springer US
Springer Nature
Publisher_xml – name: Boston : Springer US
– name: Springer US
– name: Springer Nature
References JampilekJDolezalMBuchtaVMed. Chem.2007327710.2174/1573406077806206351:CAS:528:DC%2BD2sXkvFChur4%3D
GobisKFoksHKedziaAWierzchowskaMKwapiszEZwolskaZAugustynowicz-KopećEActa Pol. Pharm.200663391:CAS:528:DC%2BD28XntV2htb0%3D
PorterAEAKatritzkyARReesCWComprehensive Heterocyclic Chemistry on CD-ROM: 7-Volume Set1997OxfordElsevier157
InderleidCBNashKALorianVAntibiotics in Laboratory Medicine1996BaltimoreWilliams and Wilkins127
NgoSCZimhonyOChungWJSayahiHJacobsWRWelchJTAntimicrob. Agents Chemother.200751243010.1128/AAC.01458-061:CAS:528:DC%2BD2sXnsVWqu70%3D
http://www.taacf.org/ TAACF Assay Results on Publically Available Compounds.
BurgiH-BDunitzJDStructure Сorrelation1994VCHWeinheim74110.1002/9783527616091
GowenBBWongMHJungKHSandersABMendenhallMBaileyKWFurutaYSidwellRWAntimicrob. Agents Chemother.200751316810.1128/AAC.00356-071:CAS:528:DC%2BD2sXhtVais7rO
UkrainetsI. V.TkachA. A.GrinevichL. A.TurovA. V.BevzO. V.Khim. Geterotsikl. Soedin.200945718
ZefirovYu VKristallografiya1997429361:CAS:528:DyaK2sXnslSnur8%3D
UkrainetsI. V.KravtsovaV. V.TkachA. A.RybakovV. B.Khim. Geterotsikl. Soedin.200945875
FurutaYTakahashiKFukudaYKunoMKamiyamaTKozakiKNomuraNEgawaHMinamiSWatanabeYNaritaHShirakiKAntimicrob. Agents Chemother.20024697710.1128/AAC.46.4.977-981.20021:CAS:528:DC%2BD38XisVSjt74%3D
El-NaggarAMAbd El-SalamAMAhmedFSLatifMSEl-CadyFAFarmaco [Sci.]1983383911:CAS:528:DyaL3sXlt1aru7Y%3D
UkrainetsI. V.MospanovaE. V.SidorenkoL. V.Khim. Geterotsikl. Soedin.2007431023
HeifetsLBHeifetsLBDrug Susceptibility in the Chemotherapy of Mycobacterial Infections1991Boca RatonCRC Press89
LangfordHMWilliamsPDHomnickCFVaccaJPFelockPJStillmockKAWitmerMVHazudaDJGabryelskiLJSchleifWABioorg. Med. Chem. Lett.20081872110.1016/j.bmcl.2007.11.0491:CAS:528:DC%2BD1cXosFWktg%3D%3D
SeitzLESulingWJReynoldsRCJ. Med. Chem.200245560410.1021/jm020310n1:CAS:528:DC%2BD38XosVCgur8%3D
KleemannAEngelJPharmaceutical Substances. Synthesis, Patents, Applications, Multimedia Viewer, Version 2.002001StuttgartGeorg Thieme Verlag
ChohanZHMushtaqSPak. J. Pharm. Sci.200013211:STN:280:DC%2BD28%2Fislymuw%3D%3D
DolezalMPalekLVinsovaJBuchtaVJampilekJKralovaKMolecules20061124210.3390/110402421:CAS:528:DC%2BD28Xjs1Shsbo%3D
UkrainetsI. V.KolesnikE. V.SidorenkoL. V.GorokhovaO. V.TurovA. V.Khim. Geterotsikl. Soedin.200642874
UkrainetsI. V.SidorenkoL. V.SlobodzianS. V.RybakovV. B.ChernyshevV. V.Khim. Geterotsikl. Soedin.2005411362
G. M. Sheldrick, SHELXTL PLUS. PC Version. A System of Computer Programs for the Determination of Crystal Structure from X-ray Diffraction Data. Rev. 5.1 (1998).
UkrainetsI. V.BereznyakovaN. L.DavidenkoA. A.SlobodzianS. V.Khim. Geterotsikl. Soedin.2009451198
ZimhonyOVilchézeCAraiMWelchJTJacobsWRAntimicrob. Agents Chemother.20075175210.1128/AAC.01369-061:CAS:528:DC%2BD2sXhsVyjsL0%3D
JulanderJGFurutaYShaferKSidwellRWAntimicrob. Agents Chemother.200751196210.1128/AAC.01494-061:CAS:528:DC%2BD2sXmtlKrsro%3D
PalekLDvorákJSvobodováMBuchtaVJampilekJDolezalMArch. Pharm. (Weinheim)20083416110.1002/ardp.2007001191:CAS:528:DC%2BD1cXhsV2rtrg%3D
ShishkinaSVShishkinOVUkrainetsIVBereznyakovaNLDavidenkoAAActa Crystallogr.2008E641031
ELNAGGAR, AM (WOS:A1983QW04000004) 1983; 38
HEIFETS LB (WOS:000274590100006.8) 1991
UKRAINETS IV (WOS:000274590100006.20) 2005; 41
Ukrainets, IV (WOS:000269529600009) 2009; 45
Gowen, BB (WOS:000249175400018) 2007; 51
UKRAINETS IV (WOS:000274590100006.23) 2007; 43
Gobis, Katarzyna (MEDLINE:17515328); 63
Zimhony, O (WOS:000243900600050) 2007; 51
Chohan, Z H (MEDLINE:16414835) 2000; 13
BURGI HB (WOS:000274590100006.1) 1994; 2
Julander, JG (WOS:000246991400011) 2007; 51
Ukrainets, IV (WOS:000272158000007) 2009; 45
Jampilek, J (WOS:000253604500008) 2007; 3
Palek, L (WOS:000252649700007) 2008; 341
UKRAINETS IV (WOS:000274590100006.21) 2006; 42
INDERLIED CB (WOS:000274590100006.9) 1996
ZEFIROV YV (WOS:000274590100006.26) 1997; 42
Dolezal, M (WOS:000238940100003) 2006; 11
PORTER AEA (WOS:000274590100006.16) 1984; 3
Ukrainets, IV (WOS:000270826500010) 2009; 45
Shishkina, SV (WOS:000256441200166) 2008; 64
Seitz, LE (WOS:000179632500021) 2002; 45
Ngo, SC (WOS:000247665800020) 2007; 51
Furuta, Y (WOS:000174597000006) 2002; 46
KLEEMANN A (WOS:000274590100006.12) 2001
Langford, HM (WOS:000253410100053) 2008; 18
SHELDRICK GM (WOS:000274590100006.18) 1998
HM Langford (384_CR8) 2008; 18
A Kleemann (384_CR9) 2001
O Zimhony (384_CR15) 2007; 51
384_CR28
L Palek (384_CR14) 2008; 341
K Gobis (384_CR4) 2006; 63
JG Julander (384_CR6) 2007; 51
ZH Chohan (384_CR3) 2000; 13
384_CR24
384_CR23
H-B Burgi (384_CR20) 1994
BB Gowen (384_CR7) 2007; 51
Yu V Zefirov (384_CR21) 1997; 42
SV Shishkina (384_CR25) 2008; E64
LE Seitz (384_CR12) 2002; 45
384_CR1
384_CR18
LB Heifets (384_CR26) 1991
384_CR17
384_CR16
AM El-Naggar (384_CR2) 1983; 38
384_CR22
Y Furuta (384_CR5) 2002; 46
CB Inderleid (384_CR27) 1996
J Jampilek (384_CR10) 2007; 3
AEA Porter (384_CR19) 1997
SC Ngo (384_CR11) 2007; 51
M Dolezal (384_CR13) 2006; 11
References_xml – volume: 43
  start-page: 863
  year: 2007
  ident: WOS:000274590100006.23
  publication-title: CHEM HETEROCYCL COMP
  contributor:
    fullname: UKRAINETS IV
– volume: 18
  start-page: 721
  year: 2008
  ident: WOS:000253410100053
  article-title: Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors
  publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
  doi: 10.1016/j.bmcl.2007.11.049
  contributor:
    fullname: Langford, HM
– volume: 3
  start-page: 277
  year: 2007
  ident: WOS:000253604500008
  article-title: Antimicrobial evaluation of some arylsulfanylpyrazinecarboxylic acid derivatives
  publication-title: MEDICINAL CHEMISTRY
  contributor:
    fullname: Jampilek, J
– volume: 2
  start-page: 741
  year: 1994
  ident: WOS:000274590100006.1
  publication-title: STRUCTURE CORRELATIO
  contributor:
    fullname: BURGI HB
– volume: 46
  start-page: 977
  year: 2002
  ident: WOS:000174597000006
  article-title: In vitro and in vivo activities of anti-influenza virus compound T-705
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.46.4.977-981.2002
  contributor:
    fullname: Furuta, Y
– start-page: 127
  year: 1996
  ident: WOS:000274590100006.9
  publication-title: ANTIBIOTICS LAB MED
  contributor:
    fullname: INDERLIED CB
– volume: 45
  start-page: 698
  year: 2009
  ident: WOS:000270826500010
  article-title: 4-HYDROXY-2-QUINOLONES 155. BIOREVERSIBLE CHEMICAL MODIFICATION OF CHINOXYCAINE AT THE TERTIARY AMINO GROUP AS A METHOD OF IMPROVING ITS PHARMACEUTICAL ACTIVITY
  publication-title: CHEMISTRY OF HETEROCYCLIC COMPOUNDS
  contributor:
    fullname: Ukrainets, IV
– volume: 45
  start-page: 5604
  year: 2002
  ident: WOS:000179632500021
  article-title: Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm020310n
  contributor:
    fullname: Seitz, LE
– volume: 51
  start-page: 1962
  year: 2007
  ident: WOS:000246991400011
  article-title: Activity of T-1106 in a hamster model of yellow fever virus infection
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.01494-06
  contributor:
    fullname: Julander, JG
– volume: 45
  start-page: 952
  year: 2009
  ident: WOS:000272158000007
  article-title: 4-Hydroxy-2-quinolones. 167*. Study of the reaction of ethyl 1-alkyl-substituted 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylates with phosphorus oxychloride
  publication-title: CHEMISTRY OF HETEROCYCLIC COMPOUNDS
  doi: 10.1007/s10593-009-0367-7
  contributor:
    fullname: Ukrainets, IV
– volume: 3
  start-page: 157
  year: 1984
  ident: WOS:000274590100006.16
  publication-title: COMPREHENSIVE HETERO
  contributor:
    fullname: PORTER AEA
– start-page: 89
  year: 1991
  ident: WOS:000274590100006.8
  publication-title: DRUG SUSCEPTIBILITY
  contributor:
    fullname: HEIFETS LB
– volume: 42
  start-page: 936
  year: 1997
  ident: WOS:000274590100006.26
  publication-title: KRISTALLOGRAFIYA
  contributor:
    fullname: ZEFIROV YV
– year: 1998
  ident: WOS:000274590100006.18
  publication-title: SHELXTL PLUS PC VERS
  contributor:
    fullname: SHELDRICK GM
– volume: 11
  start-page: 242
  year: 2006
  ident: WOS:000238940100003
  article-title: Substituted pyrazinecarboxamides: Synthesis and biological evaluation
  publication-title: MOLECULES
  contributor:
    fullname: Dolezal, M
– volume: 51
  start-page: 752
  year: 2007
  ident: WOS:000243900600050
  article-title: Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.01369-06
  contributor:
    fullname: Zimhony, O
– volume: 51
  start-page: 2430
  year: 2007
  ident: WOS:000247665800020
  article-title: Inhibition of isolated mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.01458-06
  contributor:
    fullname: Ngo, SC
– volume: 341
  start-page: 61
  year: 2008
  ident: WOS:000252649700007
  article-title: Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles
  publication-title: ARCHIV DER PHARMAZIE
  doi: 10.1002/ardp.200700119
  contributor:
    fullname: Palek, L
– volume: 45
  start-page: 567
  year: 2009
  ident: WOS:000269529600009
  article-title: 4-Hydroxy-2-quinolones. 154. Pyrimidin-2-ylamides of 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acids. Synthesis, structure, and properties
  publication-title: CHEMISTRY OF HETEROCYCLIC COMPOUNDS
  doi: 10.1007/s10593-009-0297-4
  contributor:
    fullname: Ukrainets, IV
– year: 2001
  ident: WOS:000274590100006.12
  publication-title: PHARM SUBSTANCES SYN
  contributor:
    fullname: KLEEMANN A
– volume: 13
  start-page: 21
  year: 2000
  ident: MEDLINE:16414835
  article-title: Antibacterial cobalt(II) and zinc(II) complexes of pyrazine-derived NNO and NNN donor Schiff-bases.
  publication-title: Pakistan journal of pharmaceutical sciences
  contributor:
    fullname: Chohan, Z H
– volume: 63
  start-page: 39
  ident: MEDLINE:17515328
  article-title: Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety.
  publication-title: Acta poloniae pharmaceutica
  contributor:
    fullname: Gobis, Katarzyna
– volume: 42
  start-page: 765
  year: 2006
  ident: WOS:000274590100006.21
  publication-title: CHEM HETEROCYCL COMP
  contributor:
    fullname: UKRAINETS IV
– volume: 38
  start-page: 391
  year: 1983
  ident: WOS:A1983QW04000004
  article-title: SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SOME NEW 2-(AMINOACYL- AND DIPEPTIDYL-)AMINOPYRAZINE DERIVATIVES
  publication-title: FARMACO-EDIZIONE SCIENTIFICA
  contributor:
    fullname: ELNAGGAR, AM
– volume: 64
  start-page: O1031
  year: 2008
  ident: WOS:000256441200166
  article-title: 2-bromomethyl-N-isopropyl-7,8-dimethoxy-1,2-dihydro-1,3-oxazolo[3,2-a]quinoline-4-carboxamide
  publication-title: ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS
  doi: 10.1107/S1600536808013378
  contributor:
    fullname: Shishkina, SV
– volume: 41
  start-page: 1158
  year: 2005
  ident: WOS:000274590100006.20
  publication-title: CHEM HETEROCYCL COMP
  contributor:
    fullname: UKRAINETS IV
– volume: 51
  start-page: 3168
  year: 2007
  ident: WOS:000249175400018
  article-title: In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.00356-07
  contributor:
    fullname: Gowen, BB
– volume: 51
  start-page: 1962
  year: 2007
  ident: 384_CR6
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01494-06
  contributor:
    fullname: JG Julander
– ident: 384_CR23
– start-page: 127
  volume-title: Antibiotics in Laboratory Medicine
  year: 1996
  ident: 384_CR27
  contributor:
    fullname: CB Inderleid
– volume: 45
  start-page: 5604
  year: 2002
  ident: 384_CR12
  publication-title: J. Med. Chem.
  doi: 10.1021/jm020310n
  contributor:
    fullname: LE Seitz
– volume: 11
  start-page: 242
  year: 2006
  ident: 384_CR13
  publication-title: Molecules
  doi: 10.3390/11040242
  contributor:
    fullname: M Dolezal
– volume: 51
  start-page: 3168
  year: 2007
  ident: 384_CR7
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.00356-07
  contributor:
    fullname: BB Gowen
– volume: 63
  start-page: 39
  year: 2006
  ident: 384_CR4
  publication-title: Acta Pol. Pharm.
  contributor:
    fullname: K Gobis
– volume: 18
  start-page: 721
  year: 2008
  ident: 384_CR8
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2007.11.049
  contributor:
    fullname: HM Langford
– ident: 384_CR16
– volume: 341
  start-page: 61
  year: 2008
  ident: 384_CR14
  publication-title: Arch. Pharm. (Weinheim)
  doi: 10.1002/ardp.200700119
  contributor:
    fullname: L Palek
– volume: 3
  start-page: 277
  year: 2007
  ident: 384_CR10
  publication-title: Med. Chem.
  doi: 10.2174/157340607780620635
  contributor:
    fullname: J Jampilek
– start-page: 157
  volume-title: Comprehensive Heterocyclic Chemistry on CD-ROM: 7-Volume Set
  year: 1997
  ident: 384_CR19
  contributor:
    fullname: AEA Porter
– start-page: 741
  volume-title: Structure Сorrelation
  year: 1994
  ident: 384_CR20
  doi: 10.1002/9783527616091
  contributor:
    fullname: H-B Burgi
– volume: 51
  start-page: 2430
  year: 2007
  ident: 384_CR11
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01458-06
  contributor:
    fullname: SC Ngo
– volume: 13
  start-page: 21
  year: 2000
  ident: 384_CR3
  publication-title: Pak. J. Pharm. Sci.
  contributor:
    fullname: ZH Chohan
– volume-title: Pharmaceutical Substances. Synthesis, Patents, Applications, Multimedia Viewer, Version 2.00
  year: 2001
  ident: 384_CR9
  contributor:
    fullname: A Kleemann
– ident: 384_CR18
– ident: 384_CR28
– ident: 384_CR24
– start-page: 89
  volume-title: Drug Susceptibility in the Chemotherapy of Mycobacterial Infections
  year: 1991
  ident: 384_CR26
  contributor:
    fullname: LB Heifets
– ident: 384_CR22
– volume: 38
  start-page: 391
  year: 1983
  ident: 384_CR2
  publication-title: Farmaco [Sci.]
  contributor:
    fullname: AM El-Naggar
– volume: 42
  start-page: 936
  year: 1997
  ident: 384_CR21
  publication-title: Kristallografiya
  contributor:
    fullname: Yu V Zefirov
– ident: 384_CR17
– volume: 46
  start-page: 977
  year: 2002
  ident: 384_CR5
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.46.4.977-981.2002
  contributor:
    fullname: Y Furuta
– ident: 384_CR1
– volume: 51
  start-page: 752
  year: 2007
  ident: 384_CR15
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01369-06
  contributor:
    fullname: O Zimhony
– volume: E64
  start-page: 1031
  year: 2008
  ident: 384_CR25
  publication-title: Acta Crystallogr.
  contributor:
    fullname: SV Shishkina
SSID ssj0007184
Score 1.8519895
Snippet 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to...
Source Web of Science
SourceID crossref
webofscience
springer
fao
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1058
SubjectTerms 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides
2-aminopyrazine
antitubercular activity
bromination
Chemistry
Chemistry and Materials Science
Chemistry, Organic
Organic Chemistry
Pharmacy
Physical Sciences
Science & Technology
X-ray structural analysis
Title 4-Hydroxy-2-quinolones. 168. Synthesis, chemical and antitubercular properties of 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides
URI https://link.springer.com/article/10.1007/s10593-009-0384-6
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000274590100006
Volume 45
WOS 000274590100006
WOSCitedRecordID wos000274590100006
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELb2cYAL4qktj5UPe4KdKnYctzl2y5YKJA4slZZT5CdEoLSkXYn-Gv4qM3mUIq0QHKJIkWM7Hmfm88z4M2NnMUSZhESBVz6CikkGFlEy5GbsrRQObXKTIPtezxfq7XV2fcDkznVRfR32EclGUe_tdcso1Yx8-elYgT5kx4gdFC24FnKy076oa1V_eloqpOwjmbdV8YctOoxmuRcOvdUQNUZndp_d69Ain7TifcAOQvWQ3Zn2h7Q9Yj8VzLeeUlFAwvebkrzkqLyGXOjxkF9tK8R363J9zl1HDMBN5fGiBAEb6iYJla_IIV8TsypfRi7gAyj4sqt1-WMJ4lyCL5tnbSOITSEFZ2qLhb6VjhtXer7a1sRWjS9tcaKVPqwfs8Xs8uN0Dt2ZC-BwtDYQRolRufDa6rGmII0wMrpEBemtDcFkGvGLMTZxoxyXJtKmaXAhEz530Qvv0yfsqMIPPWE8Rlz95DbR0qOpVMpYYaKhcH7qlMvtgL3sR79YtdQaxW8SZRJVgaIqSFSFHrATlE9hPqPqKxZXkgKuYoSKOksH7FUvtKL7Add_q-hsX667llsmH9qJ25jwARP_UmzaEakTgcDm6X915Bm720amKF_tOTva1DfhBQKcjT1lx5OL1xczur_59O7ytJnhvwCwufMX
link.rule.ids 315,783,787,27937,27938,41094,41536,42163,42605,52124,52247
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZoOZQL4qkuTx96gk4VO453c6xWVAuUHmhX6s3yEyKh3SXZSuyv4a8yk8eySBWCQy6RYyceZ2bs7_Nnxo5STDKLmYKgQgKVsgIcZslQ2klwUniMyS1B9kLP5urDdXHd7-NuBrb7AEm2nnpns1tBXDNazM8nCvQeu0vy6sTjm8vTrftFZ6uG49NyIeUAZd5WxR_BaC_Z5Q4eemskaqPO2QN2v08X-Wln34fsTlw8YgfT4ZS2x-yngtkmEBcFJHy_qWiZHL3XCRd6csIvNwtM8JqqOea-VwbgdhHwIoaAi3XLQuUrWpGvSVqVLxMX8BkUfN3WuvyxBHEsIVTtva4RTE4hB29rh4W-VZ5bXwW-2tQkV40PbXCkVSE2T9j87N3VdAb9oQvgsbfWEMeZVaUI2umJJpRGWJl8pqIMzsVoC40JjLUu8-MS5ybS5Xn0sRCh9CmIEPKnbH-BH3rIeEo4_SldpmXAWKmUdcImS3h-7pUv3Yi9GXrfrDptDfNbRZlMZdBUhkxl9Igdon2M_YK-z8wvJSGuYoyeushH7O1gNNP_gc3fKjrateu25U7Kh7bitjF8xMS_FJv2SuqkILB-9l8v8podzK4-nZvz9xcfn7N7HUxF5LUXbH9d38SXmO2s3at2dP8CZqrzbA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB7RVAIulKcaWmAPPUE39a7XTnysQkOgqEKUSOVk9gkWyAm2I5H-Gf4qs36EgCoE4uCLZe9zdmZ259tvAA6cdTywgaBGGEeFCyKq0EumiRwZxZlGm1wDZM_i6Uy8uogu2jynZYd270KSzZ0Gz9KUV0cL4442Lr5FHnfmD_bDkaDxFmwLhjuVHmwfv3h_erJWxqh6RZdMLWScd4HNqwr5xTRtOTnfiI5eaZdqGzTZgQ9d6xvoyefBslIDffkbseN_dO823Gr9U3LcCNQduGbzu3Bj3KWFuwffBZ2ujG8B5fTrMvPn8qguB4TFowE5X-XoUZZZeUh0S0VAZG7w8ZAEZYsa9koWPgRQeC5XMneE0bdU0E_rUuff5pQdcmqy-l1TCXrDNKRaFgo_-pJpInVmyGJVeH5s_GmFop0ZW96H2eTk3XhK2ywPVOOEVNQOAykSZmIVj2IfFmKSOx0Iy41S1sooRo9JShXoYYKbIa7C0GobMZNoZ5gx4QPo5djRXSDO4X4rUUHMDRpnIaRi0kkPIAi10Inqw9NugtNFQ-aR_qRt9mOe4pinfszTuA-7KAKp_IjKNp2dcx_iZUM0DVHYh2fdHKbtki__VNDBpuisa264g_zd39pp6AP7m8_GLXW7pyyoHv5TQ57A9TfPJ-nrl2ene3CzCYt5sNw-9KpiaR-hd1Wpx-0K-gG2jhkm
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=4-Hydroxy-2-quinolones.+168.+Synthesis%2C+chemical+and+antitubercular+properties+of+1-R-4-hydroxy-2-oxo-1%2C2-dihydroquinoline-3-carboxylic+acid+pyrazin-2-ylamides&rft.jtitle=Chemistry+of+heterocyclic+compounds+%28New+York%2C+N.Y.+1965%29&rft.au=Ukrainets%2C+I.+V&rft.au=Grinevich%2C+L.+A&rft.au=Tkach%2C+A.+A&rft.au=Bevz%2C+O.+V&rft.date=2009-09-01&rft.pub=Boston+%3A+Springer+US&rft.issn=0009-3122&rft.eissn=1573-8353&rft.volume=45&rft.issue=9&rft.spage=1058&rft.epage=1068&rft_id=info:doi/10.1007%2Fs10593-009-0384-6&rft.externalDocID=US201301711153
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3122&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3122&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3122&client=summon